We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$122B
AUM Growth
+$51B
Cap. Flow
+$46.1B
Cap. Flow %
37.82%
Top 10 Hldgs %
12.48%
Holding
2,601
New
156
Increased
1,070
Reduced
644
Closed
53

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.39B
2
AAPL icon
Apple
AAPL
+$1.66B
3
AMZN icon
Amazon
AMZN
+$1.51B
4
META icon
Meta Platforms (Facebook)
META
+$1.24B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.16B

Top Sells

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$644M
2
CAT icon
Caterpillar
CAT
+$266M
3
DKNG icon
DraftKings
DKNG
+$140M
4
ORCL icon
Oracle
ORCL
+$123M
5
EQR icon
Equity Residential
EQR
+$112M

Sector Composition

Rank Sector Weight
1 Technology 24.17%
2 Healthcare 14.82%
3 Financials 12.96%
4 Consumer Discretionary 10.52%
5 Industrials 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
2076
Seres Therapeutics
MCRB
$48.1M
$55K ﹤0.01%
116
NSIT icon
2077
Insight Enterprises
NSIT
$3.55B
$55K ﹤0.01%
547
-341
-38% -$34.5K
OCGN icon
2078
Ocugen
OCGN
$410M
$55K ﹤0.01%
+6,866
New +$57.9K
SHOE
2079
Shoe Station Group
SHOE
$395M
$55K ﹤0.01%
1,548
MGLN
2080
DELISTED
Magellan Health Services, Inc.
MGLN
$55K ﹤0.01%
584
ENLC
2081
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$54K ﹤0.01%
8,431
BCEL
2082
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$54K ﹤0.01%
6,366
+5,599
+730% +$57.4K
HNGR
2083
DELISTED
Hanger Inc.
HNGR
$54K ﹤0.01%
2,117
APEI icon
2084
American Public Education
APEI
$875M
$53K ﹤0.01%
1,858
+1,008
+119% +$30.4K
BGS icon
2085
B&G Foods
BGS
$285M
$53K ﹤0.01%
1,625
-3,629
-69% -$112K
RETA
2086
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$53K ﹤0.01%
371
-360
-49% -$40.7K
AGEN
2087
Agenus
AGEN
$249M
$52K ﹤0.01%
485
+318
+190% +$23.8K
TCBK icon
2088
TriCo Bancshares
TCBK
$1.85B
$52K ﹤0.01%
1,212
BANR icon
2089
Banner Corp
BANR
$2.39B
$51K ﹤0.01%
938
EGBN icon
2090
Eagle Bancorp
EGBN
$867M
$51K ﹤0.01%
909
OCUL icon
2091
Ocular Therapeutix
OCUL
$1.86B
$51K ﹤0.01%
3,590
+2,406
+203% +$36.6K
TMP icon
2092
Tompkins Financial
TMP
$1.45B
$51K ﹤0.01%
660
PDCO
2093
DELISTED
Patterson Companies, Inc.
PDCO
$51K ﹤0.01%
1,682
-1,532
-48% -$51.6K
GBT
2094
DELISTED
Global Blood Therapeutics, Inc.
GBT
$51K ﹤0.01%
1,462
-201
-12% -$7.85K
AMSF icon
2095
AMERISAFE
AMSF
$569M
$50K ﹤0.01%
830
-252
-23% -$16K
AIR icon
2096
AAR Corp
AIR
$5.15B
$49K ﹤0.01%
1,279
CVCO icon
2097
Cavco Industries
CVCO
$4.39B
$49K ﹤0.01%
220
GSAT icon
2098
Globalstar
GSAT
$10.2B
$49K ﹤0.01%
+1,834
New +$36K
HWKN icon
2099
Hawkins
HWKN
$2.91B
$49K ﹤0.01%
1,492
IRWD icon
2100
Ironwood Pharmaceuticals
IRWD
$611M
$49K ﹤0.01%
3,790

Similar funds

Macquarie Group's Q2 2021 Portfolio in Review

As of Q2 2021, Macquarie Group held 2,601 positions worth $122B, up 72% from $70.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group deployed $46.1B of net new capital in Q2 2021, opening 156 new positions and adding to 1,070 existing holdings. Its largest new stake was Canada Goose Holdings: 4,239,426 shares worth $185M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Mondelez International, an estimated $644M trimmed.

  • Macquarie Group's largest Q2 2021 buy was Canada Goose Holdings: 4,239,426 shares worth $185M.
  • Macquarie Group added most to Microsoft in Q2 2021, an estimated $2.39B increase.
  • Macquarie Group's biggest Q2 2021 reduction was Mondelez International, cutting an estimated $644M.
  • Macquarie Group fully exited GenMark Diagnostics, Inc in Q2 2021, selling an estimated $60.9M.
  • Macquarie Group's ten largest holdings make up 12% of its $122B portfolio in Q2 2021.
  • Macquarie Group opened 156 new positions and closed 53 in Q2 2021.
  • Macquarie Group's portfolio value rose 72% quarter-over-quarter to $122B.

Based on Macquarie Group's 13F filing for Q2 2021, filed 13 Aug 2021.